The classification and diagnostic criteria of the erythrocytoses (polycythaemias)

Clinical and Laboratory Haematology

Volumn 21, Issue 5, 1999, Pages 309-316

  Messinezy, M ^a   Pearson, T C ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Classification; Diagnosis; Erythrocytoses; Polycythaemias

Indexed keywords

ERYTHROPOIETIN;

BONE MARROW EXAMINATION; BURST FORMING UNIT E; DISEASE CLASSIFICATION; ERYTHROCYTE VOLUME; ERYTHROCYTOSIS; HUMAN; KARYOTYPE; MYELOPROLIFERATIVE DISORDER; POLYCYTHEMIA; PRIORITY JOURNAL; REVIEW; SPLENOMEGALY;

HUMANS; POLYCYTHEMIA;

EID: 0033429489     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2257.1999.00246.x     Document Type: Review

References (30)

1. Adamson J.W., Fialkow P.J., Murphy S. et al. (1976) Polycythemia vera: stem cell and probable clonal origin of the disease. New England Journal of Medicine 295, 913-916.
2. Berlin N.I. (1975) Diagnosis and classification of polycythemia. Seminars in Hematology 12, 339-351.
3. Birgegard G. & Wide L. (1992) Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment. British Journal of Haematology 81, 603-606.
4. Carneskog J., Wadenvik H., Fjälling M. & Kutti J. (1996) Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera. European Journal of Haematology 56, 158-162.
5. Champion K.M., Gilbert J.G.R., Asimakopoulos F.A. et al. (1997) Clonal haemopoiesis in normal elderly women: implications for the myeloproliferative disorders and myelodysplastic syndromes. British Journal of Haematology 97, 920-926.
6. De la Chapelle A., Träskelin A.-L. & Juvonen E. (1993) Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proceedings of the National Academy of Sciences of the United States of America 90, 4495-4499.
7. Diez Martin J.L., Graham D.L., Petitt R.M. & Dewald G.W. (1991) Chromosome studies in 104 patients with polycythemia vera. Mayo Clinic Proceedings 66, 287-299.
8. Dudley J.M., Westwood N., Leonard S. et al. (1990) Primary polycythaemia: positive diagnosis using the differential response of primitive and mature erythroid progenitors to erythropoietin, interleukin 3 and alpha-interferon. British Journal of Haematology 75, 188-194.
9. Eaves C.J. & Eaves A.C. (1978) Erythropoietin (Ep) dose-response curves for three classes of erythroid progenitors in normal human marrow and in patients with polycythemia vera. Blood 52, 1196-1210.
10. Gale R.E., Fielding A.K., Harrison C.N. & Linch D.C. (1997) Acquired skewing of X-chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age. British Journal of Haematoloay 98, 512-519.
11. Georgii A., Buhr T., Buesche G. et al. (1996) Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies. Leukemia and Lymphoma 22 (Suppl. 1), 15-29.
12. Gilbert H.S. (1995) Familial myeloproliferative disease. In: Polycythemia Vera and the Myeloproliferative Disorders (Eds. Wasserman L.R., Berk, R.D. & Berlin, N.I.). WB Saunders Company, Philadelphia, 222-225.
13. Guthrie E.L. & Pearson T.C. (1982) PCV measurement in the management of polycythaemic patients. Clinical and Laboratory Haematology 4, 257-265.
14. Hall R. & Malia R.G. (1991) Basic haematological practice. In: Medical Laboratory Haematology (Eds. Hall R. & Malia R.G.). Butterworth-Heinemann Ltd, Oxford, 84-112.
15. Kralovics R., Indrak K., Stopka T. et al. (1997) Two new epo receptor mutations: truncated epo receptors are most frequently associated with primary familial and congenital polycythemias. Blood 90, 2057-2061.
16. Messinezy M., MacDonald L.M., Nunan T.O. et al. (1997) Spleen sizing by ultrasound in polycythaemia and thrombocythaemia: comparison with SPECT. British Journal of Haematology 98, 103-107.
17. Messinezy M., Westwood N.B., Woodcock S.P. et al. (1995) Low serum erythropoietin - a strong diagnostic criterion of primary polycythaemia even at normal haemoglobin levels. Clinical and Laboratory Haematoloay 17, 217-220.
18. Modan B. & Modan M. (1968) Benign erythrocytosis. British Journal of Haematology 14, 375-381.
19. Mollison P. (1967) in Blood Transfusion in Clinical Medicine. 4th edn. Blackwell Scientific Publications, Oxford, 127.
20. Moore-Gillon J.C., Treacher D.F., Gaminara E.J. et al. (1986) Intermittent hypoxia in patients with unexplained polycythaemia. British Medical Journal 293, 588-590.
21. Najean Y., Triebel F. & Dresch C. (1981) Pure erythrocytosis: reappraisal of a study of 51 cases. American Journal of Hematology 10, 129-136.
22. Partanen S., Huvonen E., Ikkala E. & Ruutu T. (1989) Spontaneous erythroid colony formation in the differential diagnosis of erythrocytosis. European Journal of Haematology 42, 327-330.
23. Pearson T.C. & Messinezy M. (1996) The diagnostic criteria of polycythaemia rubra vera. Leukemia and Lymphoma 22 (Suppl. 1), 87-93.
24. Pearson T.C. (1991) Apparent polycythaemia. Blood Reviews 5, 205-213.
25. Pearson T.C., Guthrie D.L., Simpson J. et al. (1995) Red cell mass and plasma volume interpretation in normal adults. British Journal of Haematology 89, 748-756.
26. Pearson T.C. & Treacher D.F. (1990) Polycythaemia in systemic disease. In: Haematological Aspects of Systemic Disease (Eds. Delamore I.W. & Liu Yin J.A.). Ballière Tindall, London, 67-120.
27. Percy M.J., McMullin M.F. & Roques A.W. et al. (1998) Erythrocytosis due to a mutation in the erythropoietin receptor gene. British Journal of Haematology 100, 407-410.
28. Pierre R.V. & Whang-Peng J. (1995) Cytogenetics in polycythemia vera and the myeloproliferalive disorders. In: Polycythemia Vera and the Myeloproliferative Disorders (Eds. Wasserman L., Berk P.D. & Berlin N.I). WB Saunders Company, Philadelphia, 91-101.
29. Prchal J.T. & Sokol L. (1996) 'Benign erythrocytosis' and other familial and congenital polycythemias. European Journal of Haematology 57, 263-268.
30. Wasserman L.R., Berk P.D. & Berlin N.I. (Eds.) (1995). Polycythemia Vera and the Myeloproliferative Disorders. WB Saunders Company, Philadelphia.